News

Quality of life: Primary Debulking Surgery versus Neo-adjuv...

Quality of life: Primary Debulking Surgery versus Neo-adjuvant Chemotherapy

November 5, 2013

An international group of researchers examined quality of life factors for ovarian cancer patients enrolled in a large European clincial trial (EORTC 55971).  They compared the quality of life patients who had primary debulking surgery versus those who had neo-adjuvant chemotherapy, followed by surgery. The results, which are published in the journal Gynecologic Oncology, showed … Continued

Research

Partner Member Profile: Sherie Hildreth Ovarian Cancer Foun...

Partner Member Profile: Sherie Hildreth Ovarian Cancer Foundation

October 31, 2013

In 2004, Sherie Hildreth was diagnosed with ovarian cancer. If the disease alone wasn’t frustrating enough, there was a lack of resources and what seemed like no other women to connect with in Oregon.  During her treatment, Sherie noticed a lot of women did not have anyone to turn to, and wanted to create a … Continued

Community

New Study find Hot Ovarian Cancer Cells are Easier to Kill

New Study find Hot Ovarian Cancer Cells are Easier to Kill

October 23, 2013

Oregon State University researchers have found that using nanotechnology with heat and cytotoxic drugs can kill up to 95% of ovarian cancer cells.  While there is still additional research that needs to be done, the results of the initial study are promising for the future of ovarian cancer treatments.  Read full article here.

Research

New Clue in BRCA1 and BRCA2 Mutations

New Clue in BRCA1 and BRCA2 Mutations

October 18, 2013

A new study released in Lancet Oncology showed that abnormal levels of female hormones in the bloodstream may be why women with BRCA1 or BRCA2 mutations are at a higher risk for breast and ovarian cancer and not other cancers.  UCL Department of Women’s Cancer completed the study that found different levels of the female hormones … Continued

Research

DNA "Tags" Could Guide Treatment

DNA "Tags" Could Guide Treatment

October 17, 2013

A new study conducted by Cancer Research UK has identified chemical “tags” on DNA in patients’ tumors that could help doctors decide the type of chemotherapy women with advanced ovarian cancer should receive.  The research was published in Clinical Cancer Research. These tags, known as epigenetic markers, could be used to assess whether patients will … Continued

Research

New Discovery of Inflammation Process of Some Ovarian Cance...

New Discovery of Inflammation Process of Some Ovarian Cancer Tumors Could Help Expand Treatment

October 16, 2013

A study led by Dr. Andrew Stephens from the Prince Henry’s Institute has discovered a process that is associated with inflammation in cancers.  This discovery could lead to expanded treatment options for some types of ovarian cancer tumors.  Monash Health, Hasanuddin University, Indonesia and Lincoln Research Centre, Christchurch also participated in the study which was … Continued

Research

Ovarian Cancer News from the European Cancer Congress

Ovarian Cancer News from the European Cancer Congress

October 7, 2013

The European Cancer Congress convened in Amsterdam, the Netherlands from September 27 – October 1, 2013.  The European Cancer Congress in the main multidisciplinary and multi-professional educational meeting in oncology to take place in Europe. At ECCO, cancer specialists from around the world convene to present their research.  In this story on Medscape, Dr. Stanley … Continued

Research

Association between Marriage Status and Improved Cancer Out...

Association between Marriage Status and Improved Cancer Outcomes

October 2, 2013

Research published in Sept. 2013 in the Journal of Clinical Oncology show that patients with cancer who were married at the time of diagnosis live markedly longer compared to unmarried patients. The results, based on a large retrospective study of the National Cancer Institute’s SEER database, also report that married patients are more likely to … Continued

Research

Partner Member Profile: SHARE

Partner Member Profile: SHARE

September 30, 2013

SHARE got its start in 1976 when Dr. Eugene Thiessen, an oncologist and surgeon, invited survivors to meet informally at the Manhattan breast cancer clinic he founded. “At the time, people were not comfortable uttering the words ‘breast’ and ‘cancer’ out loud. The notion of peer support was truly innovative,” says Jacqueline Reinhard, SHARE’s executive … Continued

Community

New Cancer Insurance Checklist Helps Patients Choose a Heal...

New Cancer Insurance Checklist Helps Patients Choose a Health Insurance Plan

September 25, 2013

Many Americans will begin shopping for health insurance on October 1 through the new insurance marketplaces. As a cancer patient, you have unique health care needs that you may want to consider. The Ovarian Cancer National Alliance has partnered with 18 patient advocacy organizations to launch a new tool that will help you pick the … Continued

Advocacy

Q&A with Ron Chandler, Ph.D.

Q&A with Ron Chandler, Ph.D.

September 24, 2013

Dr. Ron Chandler is a 2013 Ann Schreiber Mentored Investigator Award recipient. In this interview with OCRF’s Sarah DeFeo, Dr. Chandler discusses his research and what it means to receive a grant from OCRF. Sarah DeFeo:  Tell us about yourself. Ron Chandler:  I am the first Ph.D. scientist in my family, although my Grandpa and Dad … Continued

Community

MD Anderson: Versatile microRNAs choke off cancer blood sup...

MD Anderson: Versatile microRNAs choke off cancer blood supply, suppress metastasis

September 11, 2013

A new study released today by MD Anderson Cancer Center in Texas shows that a family of microRNAs (miR-200) blocks cancer progression by cutting off the tumor’s ability to build new blood vessels.  These findings highlight the potential of biomarkers for identifying patients who might benefit from treatment.  Dr. Anil Sood says “safety studies will need … Continued

Research